You are here: Home » PTI Stories » National » News
Business Standard

Sun Pharma shares surge over 8%; m-cap rises by Rs 9,523 cr

Press Trust of India  |  New Delhi 

Shares of surged over 8 per cent today after the US health regulator did not recommend any action against the company's plant in

The stock jumped 8.13 per cent to settle at Rs 528.20 on BSE. Intra-day, it rose 9 per cent to Rs 532.65.

On NSE, shares of the company climbed 8 per cent to close at Rs 528.25.

The stock was the biggest gainer among blue chips on both key indices.

The company's market valuation rose by Rs 9,523.1 crore to Rs 1,26,729.10 crore.

In terms of equity volume, 16.47 lakh shares of the company were traded on BSE and over two crore shares changed hands on NSE during the day.

US health regulator USFDA has said it found objectionable conditions at Industries' plant in but did not recommend any action against the company.

In a notification on its website, the said it has issued Voluntary Action Indicated (VAI) status to the company's plant.

According to the USFDA, "objectionable conditions were found but the problems do not justify further regulatory action.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, June 08 2018. 19:55 IST